Plain-English translation of NCT07379463 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a specialized PET/CT imaging scan that uses amino acid tracers (11C/18F-MET/FET) to detect and monitor tumors. The scan works by injecting a small amount of radioactive tracer into your bloodstream, which accumulates in tumor cells and shows up on imaging. Researchers want to measure how accurate this imaging method is for finding tumors and detecting whether cancer has returned after treatment.
Current imaging methods sometimes miss tumors or cannot clearly distinguish between tumor tissue and normal tissue. This trial is exploring whether amino acid-based imaging might be more accurate at finding tumors earlier and monitoring patients more effectively after treatment.
You likely qualify if…
You likely don't qualify if…
You will receive a single injection of a radioactive amino acid tracer into your vein, then undergo a PET/CT scan imaging session. The scan takes place within a specified timeframe after the injection. No long-term follow-up visits are described—this appears to be a one-time or as-needed imaging assessment integrated into your regular medical care.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
China